After five years, Levitt is ending People I (Mostly) Admire, and will start hosting the occasional Freakonomics Radio episode. We couldn’t be happier.

• SOURCES:
  • Steve Levitt, co-author of Freakonomics and host of People I (Mostly) Admire.

• RESOURCES:
  • "How to Help Kids Succeed," by People I (Mostly) Admire (2025).
  • "Feeling Sound and Hearing Color," by People I (Mostly) Admire (2024).
  • "Richard Dawkins on God, Genes, and Murderous Baby Cuckoos," by People I (Mostly) Admire (2024).
  • "Arnold Schwarzenegger Has Some Advice for You," by People I (Mostly) Admire (2024).
  • "Drawing from Life (and Death)," by People I (Mostly) Admire (2023).
  • "Yuval Noah Harari Thinks Life is Meaningless and Amazing," by People I (Mostly) Admire (2022).
  • "Is This the Future of High School?," by People I (Mostly) Admire (2022).
  • "Does Death Have to Be a Death Sentence?," by People I (Mostly) Admire (2022).
  • "Sal Khan: 'If It Works for 15 Cousins, It Could Work for a Billion People.'" by People I (Mostly) Admire (2021).
  • "Jared Diamond on the Downfall of Civilizations — and His Optimism for Ours," by People I (Mostly) Admire (2021).
  • "Amanda & Lily Levitt Share What It’s Like to be Steve’s Daughters," by People I (Mostly) Admire (2021).
  • "How Rahm Emanuel Would Run the World," by Freakonomics Radio (2020).
  • The Levitt Lab.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

It regulates 20 percent of the U.S. economy, and its commissioner has an aggressive agenda — faster drug approvals, healthier food, cures for diabetes and cancer. How much can he deliver? (Part two of “The Freakonomics Radio Guide to Getting Better.”)

• SOURCES:
  • Marty Makary, commissioner of the Food and Drug Administration.

• RESOURCES:
  • "Clinical Trials Affected by Research Grant Terminations at the National Institutes of Health," by Vishal Patel, Michael Liu, and Anupam Jena (JAMA Internal Medicine, 2025).
  • "What the evidence tells us about Tylenol, leucovorin, and autism," by Matthew Herper (STAT, 2025).
  • "I Run the F.D.A. Pharma Ads Are Hurting Americans." by Marty Makary (New York Times, 2025).
  • Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health, by Marty Makary (2024).

• EXTRAS:
  • "Are You Really Allergic to Penicillin?" by Freakonomics Radio (2025).
  • "How to Fix the Hot Mess of U.S. Healthcare," by Freakonomics Radio (2021).
  • "Bad Medicine, Part 3: Death by Diagnosis," by Freakonomics Radio (2016).

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

We all want to stay sharp, and forestall the cognitive effects of aging. But do brain supplements actually work? Are they safe? And why doesn’t the F.D.A. even know what’s in them? (Part one of “The Freakonomics Radio Guide to Getting Better.”)

• SOURCES:
  • Marty Makary, commissioner of the Food and Drug Administration.
  • Peter Attia, physician, author, and host of The Peter Attia Drive.
  • Pieter Cohen, associate professor of medicine at Harvard Medical School, physician at the Cambridge Health Alliance.

• RESOURCES:
  • "Protein Powders and Shakes Contain High Levels of Lead," by Paris Martineau (Consumer Reports, 2025).
  • "Accuracy of Labeling of Galantamine Generic Drugs and Dietary Supplements," by Pieter Cohen, Bram Jacobs, Koenraad Van Hoorde, and Céline Vanhee (JAMA, 2024).
  • Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health, by Marty Makary (2024).
  • Outlive: The Science and Art of Longevity, by Petter Attia (2023).
  • "Revealing the hidden dangers of dietary supplements," by Jennifer Couzin-Frankel (Science, 2015).

• EXTRAS:
  • "China Is Run by Engineers. America Is Run by Lawyers." by Freakonomics Radio (2025).
  • "How to Fix the Hot Mess of U.S. Healthcare," by Freakonomics Radio (2021).

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.